StockNews.AI
BRKR
StockNews.AI
81 days

Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidence - at Speed, Depth, and Scale

1. Bruker launched the timsMetabo mass spectrometer at ASMS. 2. This device offers unmatched sensitivity for small molecules.

2m saved
Insight
Article

FAQ

Why Bullish?

The innovation positions BRKR strongly in the metabolomics market, similar to past successful launches. Historical examples suggest that product launches elevating technological capabilities often boost stock performance.

How important is it?

The introduction of a cutting-edge product like timsMetabo is vital for maintaining competitiveness, particularly in the growing metabolomics sector.

Why Long Term?

Successful integration of timsMetabo can expand market share and revenue long-term. Previous product innovations have positively influenced sustained growth.

Related Companies

BALTIMORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) launched timsMetabo, a peak-performance 4D-Metabolomics™ mass spectrometer delivering unprecedented sensitivity, separation power and annotation confidence for small molecules, further enhanced by the novel TIMS ‘MoRE' scan-mode. The timsMetabo system enables the generation of a ‘digital metabolome archive' for every sample, providing TIMS-enabled qual-quant perfor.

Related News